The influence of gastrin and/or cholecystokinin antagonists on the proliferation of three human astrocytic tumor cell lines

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 433-437

  Camby, I ^a   Salmon, I ^b   Oiry, C ^c   Galleyrand, J C ^c   Nagy, N ^a   Danguy, A ^a   Brotchi, J ^b   Pasteels, J L ^a   Martinez, J ^c   Kiss, R ^a,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c CNRS   (France)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN; GASTRIN DERIVATIVE; JMV 179; JMV 209; JMV 97; SW 1088; U 373; U 87; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 16044368830     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90006-2     Document Type: Article

References (35)

1. Wilson C B. Current concepts in cancer brain tumors. N Engl J Med 1994; 300: 1469-1471.
2. Coons S W, Johnson P C. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993; 52: 609-618.
3. Maria B L, Eskin T A, Quisling R G. Brainstem and other malignant gliomas: II. Possible mechanisms of brain infiltration by tumor cells. J Child Neurol 1993; 8: 292-305.
4. Simpson J R, Horton M D, Scott C et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (ROTG) clinical trials. Int J Radiat Oncol Biol Phys 1993; 26: 239-244.
5. Rao B R, Roelvink C A, Slotman B J. Role of steroid hormones in gliomas. In: Karim ABMF, Laws ER, eds. Glioma, principles and practice in neuro-oncology. Berlin: Springer-Verlag, 1991: 165.
6. Yager M J, Koestner A, Marushige K, Marushige Y. The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results. Acta Neuropathol 1992; 83: 624-629.
7. Marushige Y, Raju N R, Marushige K, Koestner A. Modulation of growth and morphological characteristics in glioma cells by nerve growth factor and glia maturation factor. Cancer Res 1987; 47: 4109-4115.
8. Pollack I F, Randall M S, Kristofik M P, Kelly R H, Selker R G, Vertosick F T. Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in serum-free medium. J Neurosurg 1990; 73: 106-112.
9. Maxwell M, Naber S P, Wolfe H J et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991; 51: 1345-1351.
10. Torp S H, Helseth E, Dalen A, Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 1991; 33: 61-64.
11. Rehfeld J F. Localisation of gastrin to neuro- and adenohypophysis. Nature 1978; 271: 771-773.
12. Hokfelt T, Cortes R, Schalling M et al. Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues. Neuropeptides 1991; 19: 31-43.
13. Himick B A, Peter R E. CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish. Am J Physiol 1994; 267: r841-r851.
14. Rehfeld J F, Van Solinge W W. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994; 63: 295-347.
15. Van Solinge W W, Odum L, Rehfeld J F. Ovarian cancers express and process progastrin. Cancer Res 1993; 53: 1823-1828.
16. 2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 1992; 52: 6031-6035.
17. Seva C, Dickinson C J, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994; 265: 410-412.
18. Rodriguez M, Dubreuil P, Bali J, Martinez J. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin. J Med Chem 1987; 30: 758-763.
19. Martinez J, Rodriguez M, Lignon M, Galas M. Selective cholecystokinin receptor antagonists. In: Cholecystokinin antagonists. New York: Liss, 1988: 29.
20. Lignon M, Galas M, Rodriguez M, Laur J, Aumelas A, Martinez J. A synthetic peptide derivative that is a cholecystokinin receptor antagonist. J Biol Chem 1987; 262: 7226-7231.
21. Kiss R, Salmon I, Pauwels O et al. In vitro influence of gastrin, estradiol and gonadotrophin releasing hormone on HCT-15 and Lo Vo human colorectal neoplastic cell proliferation. Eur J Cancer 1991; 27: 1268-1274.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65: 55-63.
23. Fogh J, Fogh J M, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977; 59: 221-225.
24. Ponten J, Macintyre E H. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 1968; 74: 465-486.
25. Darro F, Camby I, Kruczynski A, Pasteels J, Martinez J, Kiss R. Characterization of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol and anti-luteinizing hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract. Gut 1995; 36: 220-230.
26. Courrière P, Tremoulet M, Eche N, Armand J P. Hormonal steroid receptors in intracranial tumors and their relevance in hormone therapy. Eur J Cancer [A] 1985; 21: 711-714.
27. Poisson M, Pertuisset B F, Hauw J J et al. Steroid hormone receptors in human meningiomas, gliomas and brain metatases. J Neurooncol 1983; 1: 179-189.
28. Glick R P, Molteni A, Fors E M. Hormone binding in brain tumors. Neurosurgery 1983; 13: 513-519.
29. Camby I, Salmon I, Rorive S et al. Characterization of the influence of anti-hormone and/or growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines. J Neurooncol 1994; 20: 67-80.
30. Camby I, Salmon I, Danguy A et al. Influence of gastrin on human astrocytic tumor cell proliferation. J Natl Cancer Inst 1996; in press.
31. Ito M, Matsui T, Taniguchi T et al. Functional characterization of human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin. J Biol Chem 1993; 268: 18300-18305.
32. Pincus M R, Murphy R B, Carty R P, Chen J, Shah D, Scheraga H A. Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and opiate peptide, Met-enkephalin. Peptides 1988; 9: 145-152.
33. Staley J, Coy D H, Jensen R T, Moody T W. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines. J Mol Neurosci 1993; 4: 29-40.
34. A receptor in the human IMR-32 neuroblastoma cell line. FEBS Lett 1994; 354: 203-206.
35. Chorev M, Rubini E, Gilon C, Wormser U, Selinger Z. Synthesis of partially modified retro-inverso substance P analogues and their biological activity. J Med Chem 1983; 26: 129-135.